🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Electra Therapeutics, Inc.

ETRA Healthcare
$8.68 +$0.33 (3.95%)
Market Cap: $544.82 M
Gurus Holding
4
Popularity Rank
#2577
% of Shares Held
3.79%
Net Activity (Q3 2026)
+$26.77 M

Guru Ownership Trend

Guru Analysis for Electra Therapeutics, Inc. (ETRA)

Electra Therapeutics, Inc. (ETRA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.66 M.

Top institutional holders include Jefferies Group and George Soros.

Institutional sentiment is currently Bullish. This is evidenced by a $26.77 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position.

Key Holders

Top 5 by Value

$25.25 M
$843,750
$528,806
$150,233

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$26.77 M
Total Buy Value
New Buys 4
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
0
Net Buyers
4

FAQs for Electra Therapeutics, Inc. (ETRA)

Major holders include Jefferies Group ($25.25 M), George Soros ($843,750), Steven Cohen ($528,806). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.38 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $26.77 M, with 4 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in ETRA during the most recent reporting period.

Yes, 4 managers opened new positions in ETRA, and 0 increased their existing holdings. The total reported buy value was $26.77 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.19% New Buy 2,244,333 $25.25 M Q3 2026
0.01% New Buy 75,000 $843,750 Q3 2026
0.00% New Buy 47,005 $528,806 Q3 2026
0.00% New Buy 13,354 $150,233 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form